Loai M.

Saadah

Mobile: (+971) 50 69 42 451

Email: loai_m_s@hotmail.com

Loai Mohammed Saadah

WORK EXPERIENCES:
1. Adjunct Assistant professor, Faculty of Medicine and Health Sciences (FMHS),
United Arab Emirates University (UAEU), Al Ain, September 2015 - Current
2. Clinical Pharmacist (Licensed as Pharmacy Supervisor), Global Medical Solutions
& Zayed Military Hospital (ZMH), Abu Dhabi, March 2010 Current
3. Peer Reviewer, Sage Publishing (Previously Libertas Academica), California, USA,
August 2015 Current. Peer Reviewer for the following Journals in the Group:
a. Clinical Medicine Insights: Therapeutics (August 2015 Current)
b. Clinical Medicine Insights: Pediatrics (September 2015 Current)
c. Clinical Medicine Insights: Cardiology (December 2015 Current)
d. Clinical Medicine Insights: Endocrinology and Diabetes (September 2015
Current)
e. Journal of Central Nervous System Disease (December 2015 Current)
4. Clinical Preceptor for Graduate Students, Dubai Pharmacy College, Dubai,
September 2015 September 2016.
5. Clinical Pharmacist (Senior & Team Supervisor), Global Medical Solutions and
Zayed Military Hospital, Abu Dhabi; March 2010 2016.
6. Clinical Pharmacy Specialist (Pediatrics), Pediatric Pharmacotherapy Specialty
Group, Urban & Cure Pharmacy, Abu Dhabi, UAE; August 2008 November 2009.
7. Local Mentor, Queens University Belfast, UK, October 2008 January 2009.
8. Oncology & Clinical Pharmacy Specialist (Locum), Gulf International Cancer
Center in affiliation with the George Washington University Medical Center, Abu
Dhabi, UAE; October 2008 January 2009.
9. Clinical Pharmacy/Pharmacotherapy Specialist (Pediatrics), Tawam Hospital &
Johns Hopkins Medicine, Al Ain, UAE; December 2007 August 2008.
10. Clinical Pharmacist, Neonatal and Pediatric Intensive Care Units, Tawam Hospital
& Johns Hopkins Medicine, Al Ain, UAE; April 2007 August 2008.
11. Clinical Pharmacist(Maternity & Pediatrics), Department of Pharmaceutical
Services, Al Wasl Pediatrics and Maternity Hospital (currently known as Latifa
Hospital), Department of Health and Medical Services (DOHMS), Dubai, UAE;
August, 2005 February 2007.
12. Pharmacist In-charge, Al Shams Pharmacy, Sharjah, UAE, December 2004 July
2005.
13. Scholar, College of Pharmacy, Jordan University of Science and Technology
(JUST), Jordan; January, 2001 November, 2004.

1
Loai M. Saadah

Mobile: (+971) 50 69 42 451

Email: loai_m_s@hotmail.com

14. Research Assistant, Infectious Diseases Laboratory, College of Pharmacy (COP) -

The University of Iowa (UI), USA; June, 2001 December 2002.
15. Medical Representative, Hikma Pharmaceuticals, Jordan; May, 1999 - September,
2000

QUALIFICATIONS:
1. Board Certified Nutrition Support Pharmacist (BCNSP), Board of Pharmaceutical
Specialties, USA, 2008.
2. Advanced Cardiovascular Life Support (ACLS), American Heart Association, USA,
2008.
3. Board Certified Pharmacotherapy Specialist (BCPS), Board of Pharmaceutical
Specialties, USA, 2007.
4. Doctor of Pharmacy (PharmD.), Special Honors and High Distinction, UI, Iowa
City, Iowa, USA, 2006.
5. Master of Science (MSc) in Hospital Clinical Pharmacy, UI, Iowa City, Iowa, USA,
2002.
6. Bachelor of Science (BSc) in Pharmacy, Jordan University of Science & Technology
(JUST), Irbid, Jordan, 1999.

LEADERSHIP EXPERIENCES:
1. Helped and lead teams in JCIA accreditations for 2011, 2014, and 2017 at Zayed
Military Hospital, ZMH, Abu Dhabi, 2011 2017.
2. Organized the 1st Hospital Pharmacy Conference in Abu Dhabi, UAE, 2014.
3. Implement pharmacist-managed anticoagulation clinic at Zayed Military Hospital,
Abu Dhabi, UAE, 2014.
4. Lead and Helped in implementing intravenous admixtures and unit dose services
at Zayed Military Hospital, Abu Dhabi, UAE, 2012.
5. Lead and established together with Nursing and Medical Colleagues the first
specialized chemotherapy services at a private, day-case, cancer-treatment
medical center in the United Arab Emirates (UAE), Gulf International Cancer
Center (GICC), Al Bahiya City, Abu Dhabi, UAE, October 2008.
6. Initiate the idea and lead the project of establishing a nation-wide pediatric
pharmacotherapy specialty group in the United Arab Emirates, August 2008.
7. Initiated and lead the pharmacotherapy preparatory workshops at Tawam
Hospital in affiliation with Johns Hopkins Medicine which helped improve the
pass rate of colleagues in the board exams for the year 2008, May through
September 2008.
8. Leading Team in JCIA Accreditation in Al Wasl Hospital in 2006.

2
Loai M. Saadah

Mobile: (+971) 50 69 42 451

Email: loai_m_s@hotmail.com

9. Established pharmacy-centralized, fully automated, intravenous admixtures and

parenteral nutrition service (mostly neonatal intensive care unit patients) in Al
Wasl Hospital, Dubai, United Arab Emirates, March 21, 2006.
10. Performed complex pharmacotherapy outcomes evaluations as opposed to the
usual medication utilization reviews on injectable antibiotics in Al Wasl Hospital,
since August 2006.
11. Pioneering in the application of artificial neural networks and artificial
intelligence modeling in clinical pharmacy research.
12. Developed policies, procedures and protocols related to pharmacy practice, and
collaboration agreements with medical, and other professionals in Al Wasl
Hospital, Dubai, United Arab Emirates.

CLERKSHIPS/CLINICAL ROTATIONS:
1. Drug Inforamtics/Information and Research March 2006 July 2006.
2. Acute Care Medicine, Family Practice, Infectious Diseases, Pediatrics, Neurology,
University of Iowa Hospitals and Clinics (UIHC), May 2003 through April 2004.
3. Community Pharmacy, OSCO DRUGS, January 2004, Old Capitol, Iowa city, IA, USA
4. Community Pharmaceutical Care Osterhaus Pharmacy, December 2003, Maquoketa,
IA, USA

PROFESSIONAL MEMBERSHIPS:
1. Membership of the Cardiology Practice and Research Network, American College
of Clinical Pharmacy, 2013 Current.
2. Membership of the Critical Care Practice and Research Network, American
College of Clinical Pharmacy, 2013 Current.
3. Membership of the Pediatric Practice and Research Network, American College
of Clinical Pharmacy, 2007 Current.
4. Membership of the Hematology & Oncology Practice and Research Network,
American College of Clinical Pharmacy. (Historical)
5. Membership of the Infectious Diseases Practice and Research Network, American
College of Clinical Pharmacy, (Historical)
6. Membership of the American College of Clinical Pharmacy (ACCP), 2006
Current.
7. Membership of the American Society of Health System Pharmacists (ASHP), 2003
- Current.
8. Membership of the American Academy of Pharmaceutical Sciences (AAPS), 2002
- 2003.
9. Membership of the Jordan Pharmacists Association (JPA), 1999 - Current.

HONORS AND AWARDS:

3
Loai M. Saadah

Mobile: (+971) 50 69 42 451

Email: loai_m_s@hotmail.com

1. Employee of the Month at ZMH Pharmacy, Abu Dhabi, February 2015.

2. Appreciation Certificate from Medical Services Corps for commitment for the
educational activities within Continuing Medical Education, Undergraduate &
Postgraduate programs at Zayed Military Hospital, May 2012.
3. Best speaker certificate and award for speaking in the continuous education program for
the emirate of Abu Dhabi, July 2008.
4. Award for speaking at the first national clinical pharmacy day in the continuous
education program for the emirate of Abu Dhabi, September 20 th 2008.
5. Recognition and appreciation by Tawam Hospital in affiliation with Johns Hopkins
Medicine for passing the Board Exams in 2007 and setting the standards for colleagues
at Tawam Hospital, April 2008.
6. Finalist in the ACCP research forum, Memphis, Tennessee, April 21-24 th 2007. Study title:
Complications following elective and non-elective cesarean section: a neural network
analysis approach and prediction of post-surgical febrile morbidity and infections. Loai
M. Saadah, Ronald A. Herman, Samer S. Saadah
7. Special Honors and High Distinction, PharmD, UI, JUL. 2006.
8. Scholarship for the PharmD. and MSc in Hospital Clinical Pharmacy from JUST, JAN. 2001
NOV. 2004.
9. Deans list, College of Pharmacy UI, OCT. 2003.
10. First on class, first year Pharmacy, JUST, 1994/95.
11. First on class all through elementary and secondary school.

PUBLICATIONS:
1. Habib, M.E., Saadah, L.M., Al-Samerrae, M., Shoeib, F.E., Mamoun, M., Latif, G.A.
and Habib, D.M. (2017) Does Ringer Lactate Used in Parkland Formula for Burn
Resuscitation Adequately Restore Body Electrolytes and Proteins? Modern Plastic
Surgery, 7, 1-12.
2. Saadah MA, El Beshari M, Al Heis M, Saadah LM, al Zaabi AA, Al Bloushi AR,
Rashid G. Intracephalic glomus tumor presenting as peripheral neuropathic pain
and literature review. International Journal of Diagnostic Imaging 2016:3(1):54-
62.
3. Ghuman NK, Saadah LM, Al Najjar MS, Shaheen DY, Abdelmaksoud SI, and Al Ali
MM. Effectiveness of Liraglutide in Type II Diabetes Mellitus Management:
Experience in Emirati Patients. Clinical Medicine Insights: Endocrinology and
Diabetes 2015:8 6772
4. Saadah LM, Nazzal YM, Abdelmaksoud SI, Nazzal MK, Abu Sabiha EL, Al Qasemi
AA. Predictors of Physicians Acceptance of Clinical Pharmacy Recommendations
ata Military Hospital in the United Arab Emirates. Int J Pharm 2014; 4(4):78-85.
5. Saadah M, El Beshari M, Saadah LM, Hamdallah H, Alloub Z, Al Zaabi A, Ben-
Mussa A, Ben-Nour A. Progressive Myoclinic Epilepsy Type I. Report of an Emirati
Family and Literature Review. Epilepsy and Behavior Case Reports. 2014; 2:112-
117.

4
Loai M. Saadah

Mobile: (+971) 50 69 42 451

Email: loai_m_s@hotmail.com

6. Saadah LM, Chedid F, Sohail R, Nazzal Y, Al Kaabi M, Rahmani A. Palivizumab

Prophylaxis during nosocomial outbreaks of respiratory syncytial virus in a
neonatal intensive care unit. Predicting Effectiveness with an artificial neural
network model. 2014 Mar;34(3):251-9.
7. Nazzal ME, Saadah MA, Saadah LM, Al Omari MA, Al Oudat ZA, Nazzal MS, El
Beshari MY, Al Zaabi AA, Al Nuaimi YI. Management options of chronic low back
pain: a randomized blinded clinical trial. Neurosciences (Riyadh). 2013
Apr;18(2):152-9.
8. Saadah LM, Sohail MR, Uslan DZ, Friedman PA, Hayes DL, Wilson WR, Steckelberg
JM, Baddour LM. Predicting cardiac device-related infective endocarditis: artificial
neural networks versus diagnostic transesophgeal echocardiography. (In process)
9. Rajar A, Saadah M, Saadah L. Clinical Semiology and Artificial Neural Networks:
predicting computed tomography imaging results in localization-related epilepsy
syndromes. (In process)
10. Saadah LM, Herman RA. Cefuroxime with or without metronidazole versus
piperacillin and tazobactam in antimicrobial surgical prophylaxis in elective and
non-elective cesarean section: a neural network analysis approach. (In Process)
11. Saadah LM, Herman RA. Cefuroxime with or without metronidazole versus
piperacillin and tazobactam in antimicrobial surgical prophylaxis in elective and
non-elective cesarean section: from drug utilization reviews to pharmacotherapy
outcomes evaluation. (In process).
12. Saadah LM, Herman RA. Towards full integration of pharmacy electronic systems:
the development of an enterprise software solution for intravenous admixtures
and parenteral nutrition. (In process)
13. Saadah LM, Ernst EJ. ABT-773 pharmacodynamics in neutropenic murine model
for pneumococcal lung infections: different levels versus different types of
antimicrobial kill activity. (In process)
14. Saadah MA, Saadah LM. Psychiatric Presentations of Neurobrucellosis. (In
preparation).
15. Nazzal ME, Saadah MA, Saadah LM, and Trebinjac SM. Acute ischemic stroke:
Relationship of brain lesion location & functional outcome. Disability and
Rehabiliation 2009, 31(18): 1501-1506.
16. Saadah MA,Thankre M, Saadah LM and Nazzal ME. Homocysteinemia and Stroke in
Vegetarians. Neurosciences 2006, 11(2):107-111.
17. Saadah MA, Al Shunnar Q, Saadah LM, Shogan A, Afifi H and Inshasi J. Atypical
Presentations of conus medullaris and filum terminale ependymoma:A report of three
cases and literature review. Clinical Neuroscience Journal, 2004, 11:3, 268-272.
18. Saadah MA and Saadah LM. Autonomy and Rehabilitation: A critical Review of
Literature. Neurosciences, 2004, 9:2, 84-90.
19. Saadah MA and Saadah LM. Attention Deficit Hyperactivity Disorder:Future
Perspectives. International J Ther and Rehabil, 2004, 11(8):381-388.

5
Loai M. Saadah

Mobile: (+971) 50 69 42 451

Email: loai_m_s@hotmail.com

20. Hoffman HL, Klepser ME, Ernst EJ, Petzold CR, Saadah LM, Doern GV. Influence of
Macrolide Susceptibility on Efficacies of Clarithromycin and Azithromycin against
Streptococcus pneumoniae in a Murine Lung Infection Model. Antimicrobial Agents and
Chemotherapy 2003; 47:739-46.
21. Sa'adah, Loai Mohammed. The Pharmacodynamics of ABT-773, a new ketolide
antibiotic, in a neutropenic murine model of pneumococcal lung infection. 2002. Thesis
(MS)PharmacyThe University of Iowa.
22. Saadah MA, Shawabkeh A, Saadah LM and Inshasi J. Pilomotor Seizures: Symptomatic
Versus Idiopathic, Report of two cases and Literature review. Seizure-European J of
Epilepsy, 2002, 11:7,455-459.

SELECTED POSTERS:
1. Saadah L, Al Mohdar S, Murad W, Lutfi E, Al Qasemi A. Aspirin & antiplatelet effects on
coronary calcium scores & coronary artery stenosis in asymptomatic patients undergoing
Coronary Computed Tomography CTA. Military Medical Services Scientific Conference,
April 2015.
2. Al Mohdar S, Saadah L, Salad H, Al Rumaithi A, Murad W, Al Qasemi A. Middle East
Cardiac CTA Registry UAE Subdivision. Military Medical Services Scientific Conference,
April 2015.
3. Al Mohdar S, Saadah L, Salad H, Al Rumaithi A, Murad W, Al Qasemi A. Effect of Radiation
Dose During Coronary Artery Angiography Scans on Image Quality Using an Artificial
Neural Network (ANN) Model. Military Medical Services Scientific Conference, April
2015.
4. Saadah L, Rajarathinam A, Saadah M, Prabakaran E. The use of Artificial Neural Networks
in predicting the yield of computed tomography (CT) brain study in generalized epileptic
syndrome (GES) patients. 8th European Congress on Epileptology, September 21 - 25,
2008, Berlin, Germany.
5. Rajarathinam A, Saadah L, Saadah M, Prabakaran E. The use of Artificial Neural Networks
in predicting the yield of computed tomography (CT) brain study in localization-related
epileptic syndrome (LRES) patients. 8th European Congress on Epileptology, September
21 - 25, 2008, Berlin, Germany.
6. Saadah LM, Herman RA, Saadah SM. Complications following elective and non-elective
cesarean section: a neural network analysis approach and prediction of post-surgical
febrile morbidity and infections. American College of Clinical Pharmacy 2007 Spring
Practice and Research Forum, April 2125, 2007, Memphis.
7. Knechtel SA, Klepser ME, Ernst EJ, Keele D, Roling E, Sa'adah LM, Doern GV. Relationship
between clarithromycin minimum inhibitory concentration and survival in a
pneumococcal murine lung infection model. American College of Clinical Pharmacy 2007
Spring Practice and Research Forum, April 2125, 2007, Memphis.

PRESENTATIONS:
1. Saadah LM. Pearls From Pharmacy Practice. Jordan University of Science and
Technology, September 28th 2017, Irbid, Jordan. (Invited Speaker)

6
Loai M. Saadah

Mobile: (+971) 50 69 42 451

Email: loai_m_s@hotmail.com

2. Saadah LM. Pharmacotherapy update, 10th Medication Safety Conference 2017.

(Invited)
3. Saadah LM. Clinical pharmacy services; impact on Medication Safety (Improving
Patient Safety). 10th Medication Safety Conference 2017. (Invited)
4. Saadah LM. Reconciliation. 10th Medication Safety Conference 2017. (Invited)
5. Saadah LM. PCS Global Diabetes Conference (GDC-2016) August 6th and 7th 2016.
Moscow, Russia. (Invited)
6. Saadah LM. Rational Prescribing for Family Practice Residents. Medical Education
Center. Zayed Military Hospital September 8th 2014. Abu Dhabi, UAE. (Invited
Speaker)
7. Saadah LM. Pharmacists as Principal Investigators in Hospitals. 1 st Hospital
Pharmacy Conference, May 23rd 2014, Abu Dhabi, UAE. (Invited Speaker)
8. Saadah LM. Combining Artificial Intelligence and Antibodies in Clinical Research
and Practice. 6th Annual International Congress of Antibodies. April 25 28 2014.
Dalian, China. (Invited)
9. Nazzal ME, Saadah MA, Saadah LM, Al Omari MA, Al Oudat ZA, Nazzal MS.
Management Options of Chronic Low Back Pain: A Randomized Blinded Trial. Oral
Presentation Number O-116. 10th Mediterranean Congres of Physical Therapy
and Rehabilitation Medicine & 13 th National Congress of the Serbian Association
of Physical Medicine & Rehabilitation (SAPMR), Budva, Montenegro, September
29th to October 2nd 2013.
10. Saadah LM. Update on Respiratory Infections. 3rd National Clinical Pharmacy
Conference. September 13th 2013. Abu Dhabi, UAE.
11. Several Presentations at Zayed Military Hospital and Family Medicine Clinic in the
Pharmacy and Pediatrics Departments, as well as hospital-wide clinical pharmacy
seminars in the Continuous Medical Education program at Zayed Military
Hospital. Since March 2010 till now.
12. Sohail MR, Saadah LM, Uslan DZ, et al. Using artificial neural networks cardiac
rhythm management device-related infective endocarditis. Interscience
Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September
2009, San Francisco, CA, USA.
13. Saadah LM. Role of the Pediatric Clinical Pharmacy Specialist, 1 st National Clinical
Pharmacy Day, Continuous Professional Education Program, Al Raha Beach Hotel,
September 2008, Abu Dhabi, UAE. (Invited Speaker)
14. Saadah LM. Artificial neural networks in Pharmacy and Medicine. Europe
Palisade User Conference 2008, April, 2008, London, UK. (Invited speaker)
15. Saadah LM. Cardiac device-related infective endocarditis: Evaluation of
Predictors. Intensive Care Unit Continuous Education Program, Tawam Hospital,
February 2008, Al Ain, UAE. (Invited Speaker)
16. Saadah LM. Pharmacotherapy Evaluations: Borrowing into Spiral CT scan for flank
pain in the emergency department. Emergency Department Continuous
Education Program, Tawam Hospital, January 2008, Al Ain, UAE. (Invited speaker)

7
Loai M. Saadah

Mobile: (+971) 50 69 42 451

Email: loai_m_s@hotmail.com

17. Saadah LM. Applications of artificial neural networks in Neonatology. Al Ain

Pediatrics Club, March 2008, Al Ain, UAE.
18. Saadah LM, Herman RA. Complications following elective and non-elective
cesarean section: a neural network analysis and prediction of post-operative
febrile morbidity and infections. (Accepted & Finalist) for ACCP Research forum,
April 2006, Memphis, Tennessee, USA).
19. Stephanie A. Knechtel, Michael E. Klepser, Erika J. Ernst, Doug Keele, Ellen Roling,
Loai Saadah, Gary V. Doern. Relationship Between Clarithromycin Minimum
Inhibitory Concentration and Survival in a Pneumococcal Murine Lung Infection
Model. (Submitted Poster for American College of Clinical Pharmacy Research
forum, April 2006, Memphis, Tennessee, USA).
20. Saadah LM, Herman RA. Cefuroxime with or without metronidazole versus
piperacillin and tazobactam in antimicrobial surgical prophylaxis in elective and
non-elective cesarean section: from drug utilization reviews to pharmacotherapy
outcomes evaluation. Presented at 41st ASHP midyear clinical meeting, December
2006, Anaheim, California, USA.
21. Saadah LM. Artificial Neural Networks: Basic Introduction and Perspectives in
Clinical Neurology, 40th Emirates Neurology Society (EMINS) Meeting, November
2006, Dubai, United Arab Emirates. (Invited Speaker)
22. Saadah MA, Saadah LM. Neurobrucellosis at Rise of Present Millennium. American
Academy of Neurology, 58th Annual Meeting, Abstract No. 1576, 2006, San Diego,
California, USA.
23. Azba A, Saadah L, Sobhi A, Siddiqui H. Neural Networks: A true power of reason.
Presented at Dubai Pharmacy & Technology (DUPHAT) Meeting, 2006, Dubai, UAE.
24. Saadah L, Dina Dillon. Cryptosporidiosis in Patients with Human Immunodeficiency
Virus (HIV). Interns Meeting, Pharmaceutical Care Department, UIHC, 2003, Iowa city,
Iowa, USA.
25. Saadah L, Roy Davis. Hyperhomocystinemia. Interns Meeting, Pharmaceutical Care
Department, University of Iowa Hospitals & Clinics (UIHC), 2003, Iowa city, Iowa, USA.
26. Saadah L, Ernst E, Klepser M, Doern G. The pharmacokinetics and Pharmacodynamics of
ABT-773, a new ketolide antibiotic, in mice. Abstract no. W5355, AAPS meeting, 2002,
Toronto, Canada.
27. Saadah L, Ernst E. ABT-773. Clinical Pharmacy Seminar COP, UI, 2002, Iowa, USA.
28. Saadah L, Ernst E. Pneumococcal Resistance to the Macrolides. Clinical Implications.
Clinical Pharmacy Seminar COP, UI, 2001, Iowa, USA.
29. Saadah L. Injectable Antibiotics, Anaesthesia Medications, Pain Medications, (Multiple
Presentations in Group Meetings). Hikma Pharmaceuticals, 1999-2000 Jordan.

CONFERENCES:
1. Several Conferences on Medication Safety, Cold Chain Supply, Military Medicine, Various
areas of Medicine, and Clinical Pharmacy. UAE, March 2010 till now.
2. Multiple Sclerosis Preceptorship, Munich, Germany, March 2012.

8
Loai M. Saadah

Mobile: (+971) 50 69 42 451

Email: loai_m_s@hotmail.com

3. Lebanon Neurology Society Meeting, Broumana, Lebanon, September 2011.

4. DUPHAT, Dubai, UAE, March 2011.
5. Emirates Neonatal Society Meeting, Al Ain, March 2009. (Invited Speaker)
6. Symposium in Evidence-Based Neonatal Guidelines, September 2007, Sharjah UAE.
7. First Al Ain Pediatrics International Conference, May 2007, Al Ain, UAE.
8. American Society of Health System Pharmacy Midyear Clinical Meeting, December 2006,
Anaheim, California, USA.
9. American College of Clinical Pharmacy Meeting, October 2006, Saint Louis, Missouri,
USA.
10. Dubai Pharmacy and Technology Meeting, March 2006, Dubai, UAE.
11. Emirates Neurology Society International Meeting and 5 th GCC Symposium, March 2006,
Dubai, UAE.
12. Pan Arab Union of Neurological Sciences Meeting, March 2005, Jeddah, KSA.
13. ASHP Midyear, December 2003, New Orleans, Louisiana, USA.
14. American Association of Pharmaceutical Sciences (AAPS), November 2002, Toronto,
Canada.

PRESS RELEASES & RECOGNITIONS:

1. Artificial Intelligence Helps Diagnose Cardiac Infections. Mayo Clinic. Sep. 14 th 2009.
Access through http://www.disabled-world.com/news/research/artificial-
intelligence.php
2. Contributing data to Analysis Titled: Characterizing the American College of Clinical
Pharmacy Practice-Based Research Network. Pharmacotherapy 2010;30(8):264e273e.
Recognized on ACCP pages: https://www.accp.com/report/index.aspx?iss=0910&art=11

OTHER EXPERIENCES:
1. Item Development Panel Member for the Board of Pharmacotherapy Exam, ACCP, April
2008, Phoenix, Arizona, USA.
2. Judging Panel Member for Best International Paper judge for ACCP's 2015 Global
Conference, October 2015, San Francisco, California.
INTERESTS:
1. Healthcare Enterprise Solutions across the board of healthcare settings.
2. Pharmaceutical care development and practice in both the hospital and community
settings.
3. Provision of pharmaceutical care within the pharmacotherapy domain of practice.
4. Special interest in Infectious, Neurological, Cardiovascular, Nutritional and Pediatrics
Diseases Clinical Pharmacy.
5. Applying artificial intelligence, genomics, and national and international pharmacy
networking in pharmacy and medicine.
6. Medication Informatics/Information

LANGUAGES SPOKEN:
1. English (most used)

9
Loai M. Saadah

Mobile: (+971) 50 69 42 451

Email: loai_m_s@hotmail.com

2. Arabic (native language)

3. French (2nd out of 12 levels)
4. Urdu (few lay medical and pharmaceutical terms)
5. German (few words)
6. Ability to translate between languages

HOBBIES:
Swimming, Traveling, Reciting, Reading, Strategy and Tactic games.

Personal Details:

DATE OF BIRTH: October 1st 1976

PLACE OF BIRTH: Kuwait

NATIONALITY: Jordanian

MARITAL STATUS: Married

CURRENT CORRESPONDANCE ADDRESS:

P.O. Box 3740
Dr. Loai M Saadah Pharmacy Department
Zayed Military Hospital
Tel: (Home) 00971 2 55 36 241
(Work) 00971 2 40 52 028
00971 2 40 55 950
(Mobile) 00971 50 69 42 451

PERMANENT ADDRESS:
Abu Abdullah Al Qudai St. # 7.
Tareq 11947
Amman Jordan
Tel: 00962 79 20 40 892

REFERENCES:
Available upon request

10